147 related articles for article (PubMed ID: 7436165)
1. Corticosteroid-responsive hypercalcemia with elevated serum 1-alpha, 25 dihydroxyvitamin D.
Frame B; Parfitt AM
Ann Intern Med; 1980 Sep; 93(3):449-51. PubMed ID: 7436165
[TBL] [Abstract][Full Text] [Related]
2. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum 1,25-dihydroxyvitamin D concentrations in the hypercalcemia of sarcoidosis: correction by glucocorticoid therapy.
Chesney RW; Hamstra AJ; DeLuca HF; Horowitz S; Gilbert EF; Hong R; Borcherding W
J Pediatr; 1981 Jun; 98(6):919-22. PubMed ID: 7229793
[No Abstract] [Full Text] [Related]
4. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
[TBL] [Abstract][Full Text] [Related]
5. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism.
Stern PH; De Olazabal J; Bell NH
J Clin Invest; 1980 Oct; 66(4):852-5. PubMed ID: 7419722
[TBL] [Abstract][Full Text] [Related]
6. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.
Papapoulos SE; Clemens TL; Fraher LJ; Lewin IG; Sandler LM; O'Riordan JL
Lancet; 1979 Mar; 1(8117):627-30. PubMed ID: 85869
[TBL] [Abstract][Full Text] [Related]
7. Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy.
Zerwekh JE; Pak CY; Kaplan RA; McGuire JL; Upchurch K; Breslau N; Johnson R
J Clin Endocrinol Metab; 1980 Aug; 51(2):381-6. PubMed ID: 6893205
[TBL] [Abstract][Full Text] [Related]
8. Effect of parathyroidectomy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in primary hyperparathyroidism.
Bone HG; Zerwekh JE; Haussler MR; Pak CY
J Clin Endocrinol Metab; 1979 May; 48(5):877-9. PubMed ID: 429532
[TBL] [Abstract][Full Text] [Related]
9. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism.
Broadus AE; Horst RL; Lang R; Littledike ET; Rasmussen H
N Engl J Med; 1980 Feb; 302(8):421-6. PubMed ID: 7351950
[TBL] [Abstract][Full Text] [Related]
10. Increased 1,25-dihydroxycholecalciferol as a cause of abnormal calcium metabolism in sarcoidosis.
Koide Y; Kugai N; Kimura S; Fujita T; Yamashita N; Hiramoto ; Sukegawa J; Ogata E; Yamashita K
J Clin Endocrinol Metab; 1981 Mar; 52(3):494-8. PubMed ID: 6257749
[No Abstract] [Full Text] [Related]
11. Treatment of sarcoidosis-associated hypercalcemia with ketoconazole.
Bia MJ; Insogna K
Am J Kidney Dis; 1991 Dec; 18(6):702-5. PubMed ID: 1962657
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia with elevated dihydroxycholecalciferol levels and hypercalciuria. A parathyroid concentration-independent mechanism.
Silver J; Popovtzer MM
Arch Intern Med; 1984 Jan; 144(1):162-3. PubMed ID: 6691752
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcemia. A complication of advanced chronic liver disease.
Gerhardt A; Greenberg A; Reilly JJ; Van Thiel DH
Arch Intern Med; 1987 Feb; 147(2):274-7. PubMed ID: 3813745
[TBL] [Abstract][Full Text] [Related]
14. Elevated 1,25-dihydroxyvitamin D levels: occurrence with sarcoidosis with end-stage renal disease.
Maesaka JK; Batuman V; Pablo NC; Shakamuri S
Arch Intern Med; 1982 Jun; 142(6):1206-7. PubMed ID: 6896430
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D.
Barbour GL; Coburn JW; Slatopolsky E; Norman AW; Horst RL
N Engl J Med; 1981 Aug; 305(8):440-3. PubMed ID: 6894783
[No Abstract] [Full Text] [Related]
16. Serum 25 (OH) D and 24,25 (OH)2 levels in childhood nephrosis under different therapeutic regimens of steroid administration.
Kano K; Suda T
Eur J Pediatr; 1982 Mar; 138(2):162-5. PubMed ID: 7094938
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
18. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.
Klein RG; Arnaud SB; Gallagher JC; Deluca HF; Riggs BL
J Clin Invest; 1977 Jul; 60(1):253-9. PubMed ID: 874087
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia due to endogenous overproduction of 1,25-dihydroxyvitamin D in Crohn's disease.
Bosch X
Gastroenterology; 1998 May; 114(5):1061-5. PubMed ID: 9558297
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intestinal calcium absorption and circulating 1,25-dihydroxyvitamin D levels in malignancy-associated hypercalcaemia and primary hyperparathyroidism.
Ralston SH; Cowan RA; Gardner MD; Fraser WD; Marshall E; Boyle IT
Clin Endocrinol (Oxf); 1987 Mar; 26(3):281-91. PubMed ID: 3652475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
